| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.0009 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |